Alopecia Areata: Evidence-Based Treatments

被引:56
作者
Garg, Seema [1 ]
Messenger, Andrew G. [1 ]
机构
[1] Royal Hallamshire Hosp, Dept Dermatol, Sheffield S10 2JF, S Yorkshire, England
关键词
CLOBETASOL PROPIONATE 0.05-PERCENT; PLACEBO-CONTROLLED TRIAL; TOPICAL MINOXIDIL; DOUBLE-BLIND; FOLLOW-UP; TRIAMCINOLONE ACETONIDE; PHOTODYNAMIC THERAPY; HAIR-FOLLICLES; PUVA TREATMENT; DIPHENCYPRONE;
D O I
10.1016/j.sder.2008.12.002
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Alopecia areata is a common condition causing nonscarring hair loss. It may be patchy, involve the entire scalp (alopecia totalis) or whole body (alopecia universalis). Patients may recover spontaneously but the disorder can follow a course of recurrent relapses or result in persistent hair loss. Alopecia areata can cause great psychological distress, and the most important aspect of management is counseling the patient about the unpredictable nature and course of the condition as well as the available effective treatments, with details of their side effects. Although many treatments have been shown to stimulate hair growth in alopecia areata, there are limited data on their long-term efficacy and impact on quality of life. We review the evidence for the following commonly used treatments: corticosteroids (topical, intralesional, and systemic), topical sensitizers (diphenylcyclopropenone), psoralen and ultraviolet A phototherapy (PUVA), minoxidil and dithranol. Semin Cutan Med Surg 28:15-18 (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:15 / 18
页数:4
相关论文
共 68 条
[1]   Is there a role for sulfasalazine in the treatment of alopecia areata? [J].
Bakar, Oezguer ;
Gurbuz, Oya .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 57 (04) :703-706
[2]   Topical photodynamic therapy with 5-aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata [J].
Bissonnette, R ;
Shapiro, J ;
Zeng, H ;
Mclean, DI ;
Lui, H .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) :1032-1035
[3]  
Bui K, 2008, CUTIS, V81, P431
[4]  
BURTON JL, 1975, ACTA DERM-VENEREOL, V55, P493
[5]   Randomized double blind placebo-controlled trial in the treatment at alopecia areata with 0.25% desoximetasone cream [J].
Charuwichitratana, S ;
Wattanakrai, P ;
Tanrattanakorn, S .
ARCHIVES OF DERMATOLOGY, 2000, 136 (10) :1276-1277
[6]   Interventions for alopecia areata [J].
Delamere, F. M. ;
Sladden, M. M. ;
Dobbins, H. M. ;
Leonardi-Bee, J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02)
[7]   TREATMENT OF ALOPECIA AREATA TOTALIS AND UNIVERSALIS WITH CORTISONE ACETATE [J].
DILLAHA, CJ ;
ROTHMAN, S .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1952, 18 (01) :5-6
[8]   Sulfasalazine for alopecia areata [J].
Ellis, CN ;
Brown, ME ;
Voorhees, JJ .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) :541-544
[9]   Alopecia areata in a patient using infliximab: New insights into the role of tumor necrosis factor on human hair follicles [J].
Ettefagh, L ;
Nedorost, S ;
Mirmirani, P .
ARCHIVES OF DERMATOLOGY, 2004, 140 (08) :1012-1012
[10]   Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab [J].
Fabre, C. ;
Dereure, O. .
DERMATOLOGY, 2008, 216 (02) :185-186